MAPK8 and Alzheimer disease: In addition, AD patients show abnormal signal transductions such as activation of c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and glycogen synthase kinase-3, which induce neurological impairments including cell death and memory defects [97–100].